by
Lisa Chamoff, Contributing Reporter | October 18, 2021
From the October 2021 issue of HealthCare Business News magazine
Last year, the company brought the latest versions of Multiple Brain Mets SRS, Elements Cranial SRS and Elements Spine SRS to 250 customers worldwide.
Each software solution was updated with preplanning features, including Anatomical Mapping, which registers data sets to a synthetic full-body tissue model and adapts to the image modality for a more consistent and accurate segmentation; SmartBrush, which outlines cranial tumors with partial automation on multiple modalities, minimizing variability when compared to manual outlining; and Image Fusion Angio and SmartBrush Angio, which provide frameless co-registration of multiple 2D digital subtraction angiography (DSA) image pairs and angiographic 3D CT, MR and DSA image data, presents color representation of contrast flow in order to visualize temporal changes in cerebrovascular structures, and fuses and outlines intracranial vascular structures with a combination of 2D and 3D imaging data.
The company has been holding webinars at novalis-circle.org in which Brainlab customers highlight how they’re using the Elements automated software workflows together with ExacTrac Dynamic.
“Novalis Circle provides a community for our customers to share best practices and exchange knowledge to advance precision radiotherapy,” Murphy said. “Especially now, as many users are not able to join in-person meetings, live webinars provide a platform for open discussion in a remote setting.”
In 2020, Brainlab purchased Mint Medical, which provides structured reporting of radiology reads. Brainlab plans to integrate its anatomical mapping technology into the Mint software to “create an ecosystem that allows seamless flow of patient data from radiology to tumor boards, to treatment planning and follow-up,” Murphy said.
“This acquisition allows us to structure data at the start of the patient journey, front-loading the treatment planning process with more detailed and clinically relevant information,” Murphy said. “During tumor board meetings, participants will gain access to standardized reports on radiological findings to support their patient-specific treatment discussions and decisions.”
“In addition to improvements in routine clinical workflows, the combination of Brainlab and Mint Medical will improve the technological infrastructure for managing clinical trials, as well as large-scale registries and quality assurance,” Murphy said. Post treatment, integrating data from oncology and radiology will enhance the follow-up process through a systematic response assessment and patient-reported outcome measures with Visiontree.
